Mesenchymal chondroprogenitor cell origin and therapeutic potential

Stem Cell Research and Therapy

Volumn 2, Issue 1, 2011, Pages

  O'Sullivan, Janice ^a   D'Arcy, Sinéad ^a   Barry, Frank P ^a   Murphy, J Mary ^a   Coleman, Cynthia M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; PROTEOCHONDROITIN SULFATE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT STEM CELL; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICULAR CARTILAGE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOMECHANICS; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL ISOLATION; CELL MOTILITY; CELL REGENERATION; CELLULAR DISTRIBUTION; CLINICAL EFFECTIVENESS; HEMATOPOIETIC STEM CELL; HUMAN; INTERMETHOD COMPARISON; MESENCHYMAL STEM CELL; MORPHOLOGICAL TRAIT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; REVIEW; STEM CELL EXPANSION; STEM CELL GENE THERAPY; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TISSUE DISTRIBUTION; TISSUE REPAIR; WEIGHT BEARING; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; REGENERATIVE MEDICINE;

CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOARTHRITIS; REGENERATIVE MEDICINE;

EID: 80052418141     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt49     Document Type: Review

References (56)

1. Epidemiology of osteoarthritis. Davis MA, Clin Geriatr Med 1988 4 241 255 3288318 (Pubitemid 19061689)
2. The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon? Qvist P, Bay-Jensen AC, Christiansen C, Dam EB, Pastoureau P, Karsdal MA, Pharmacol Res 2008 58 1 7 10.1016/j.phrs.2008.06.001 18590824
3. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR, Am J Sports Med 2009 37 2053 2063 10.1177/0363546508328414 19251676
4. Articular cartilage engineering with autologous chondrocyte transplantation: a review of recent developments. Brittberg M, Peterson L, J Bone Joint Surg 2003 85 109 12925617
5. Targeted delivery of stem cells to osteoarthritic cartilage using lactose-modified chitosan. Curtin C, Curtin W, Scarpa T, Dockery P, Paoletti S, O'Brien T, Barry F, Murphy JM, Orthopaedic Res Soc Trans 2009 34 aper 502
6. A positive feedback loop coordinates growth and patterning in the vertebrate limb. Niswander L, Jeffrey S, Martin GR, Tickle C, Nature 1994 371 609 612 10.1038/371609a0 7935794 (Pubitemid 24315742)
7. Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFbeta signals. Karamboulas K, Dranse HJ, Underhill TM, J Cell Sci 2010 123 2068 2076 10.1242/jcs.062901 20501701
8. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. Davidson D, Blanc A, Filion D, Wang H, Plut P, Pfeffer G, Buschmann MD, Henderson JE, J Biol Chem 2005 280 20509 20515 10.1074/jbc.M410148200 15781473 (Pubitemid 40776751)
9. ClinicalTrials.gov: Study of AS902330 (rhFGF-18) Administered Intraarticularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement. http://www.clinicaltrials.gov/ct2/show/NCT00911469? term=cartilage+AND+cell&rank=10
10. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, Bonaventure J, Mech Dev 1998 77 19 30 10.1016/S0925-4773(98)00133-6 9784595 (Pubitemid 28508981)
11. Fibroblast growth factor receptors in in vitro and in vivo chondrogenesis: relating tissue engineering using adult mesenchymal stem cells to embryonic development. Hellingman CA, Koevoet W, Kops N, Farrell E, Jahr H, Liu W, de Jong RJ, Frenz DA, van Osch GJ, Tissue Eng Part A 2010 16 545 556 10.1089/ten.tea.2008.0551 19728793
12. Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. Hatakeyama Y, Tuan RS, Shum L, J Cell Biochem 2004 91 1204 1217 10.1002/jcb.20019 15048875
13. Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Chimal-Monroy J, Diaz de Leon L, Int J Dev Biol 1999 43 59 67 10213083 (Pubitemid 29099947)
14. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR, J Biol Chem 1995 270 27489 27494 10.1074/jbc.270.46.27489 7499206
15. Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. Oh CD, Chang SH, Yoon YM, Lee SJ, Lee YS, Kang SS, Chun JS, J Biol Chem 2000 275 5613 5619 10.1074/jbc.275.8.5613 10681543 (Pubitemid 30115199)
16. Biology and pathology of Rho GTPase, PI-3 kinase-Akt, and MAP kinase signaling pathways in chondrocytes. Beier F, Loeser RF, J Cell Biochem 2010 110 573 580 10.1002/jcb.22604 20512918
17. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Jian H, Shen X, Liu I, Semenov M, He X, Wang XF, Genes Dev 2006 20 666 674 10.1101/gad.1388806 16543220
18. Wnt regulation of chondrocyte differentiation. Church V, Nohno T, Linker C, Marcelle C, Francis-West P, J Cell Sci 2002 115 4809 4818 10.1242/jcs.00152 12432069 (Pubitemid 36054634)
19. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Yang Y, Topol L, Lee H, Wu J, Development 2003 130 1003 1015 10.1242/dev.00324 12538525 (Pubitemid 36372019)
20. Wnt signaling in cartilage development and degeneration. Chun JS, Oh H, Yang S, Park M, BMB Rep 2008 41 485 494 18682032
21. A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Koyama E, Shibukawa Y, Nagayama M, Sugito H, Young B, Yuasa T, Okabe T, Ochiai T, Kamiya N, Rountree RB, Kingsley DM, Iwamoto M, Enomoto-Iwamoto M, Pacifici M, Dev Biol 2008 316 62 73 10.1016/j.ydbio.2008.01.012 18295755
22. Notch receptor and Notch ligand expression in developing avian cartilage. Williams R, Nelson L, Dowthwaite GP, Evans DJ, Archer CW, J Anat 2009 215 159 169 10.1111/j.1469-7580.2009.01089.x 19490397
23. Notch signaling through Jagged-1 is necessary to initiate chondrogenesis in human bone marrow stromal cells but must be switched off to complete chondrogenesis. Oldershaw RA, Tew SR, Russell AM, Meade K, Hawkins R, McKay TR, Brennan KR, Hardingham TE, Stem Cells 2008 26 666 674 10.1634/stemcells.2007- 0806 18192230
24. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Grogan SP, Olee T, Hiraoka K, Lotz MK, Arthritis Rheum 2008 58 2754 2763 10.1002/art.23730 18759300
25. HIF1alpha regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E, Development 2007 134 3917 3928 10.1242/dev.008441 17913788 (Pubitemid 350187350)
26. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ, Min BH, Chun JS, Nat Med 2010 16 687 693 10.1038/nm.2153 20495569
27. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Barry F, Boynton RE, Liu B, Murphy JM, Exp Cell Res 2001 268 189 200 10.1006/excr.2001.5278 11478845 (Pubitemid 32744650)
28. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. Arai F, Ohneda O, Miyamoto T, Zhang X, Suda T, J Exp Med 2002 195 1549 10.1084/jem.20011700 12070283 (Pubitemid 34666069)
29. A comparative assessment of cartilage and joint fat pad as a potential source of cells for autologous therapy development in knee osteoarthritis. English A, Jones E, Corscadden D, Henshaw K, Chapman T, Emery P, McGonagle D, Rheumatology 2007 46 1676 10.1093/rheumatology/kem217 17901063 (Pubitemid 350018489)
30. Comparison of multi-lineage cells from human adipose tissue and bone marrow. De Ugarte D, Morizono K, Elbarbary A, Alfonso Z, Zuk P, Zhu M, Dragoo J, Ashjian P, Thomas B, Benhaim P, Cells Tissues Organs 2003 174 101 109 10.1159/000071150 (Pubitemid 36819010)
31. Osteogenesis in transplants of bone marrow cells. Friedenstein A, Piatetzky-Shapiro I, Petrakova K, J Embryol Exp Morphol 1966 16 381 390
32. Multilineage potential of adult human mesenchymal stem cells. Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J, Moorman M, Simonetti D, Craig S, Marshak D, Science 1999 284 143 10.1126/science.284.5411.143 10102814 (Pubitemid 29282067)
33. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
34. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, O'Connor KC, Stem Cells 2010 28 788 798 10.1002/stem.312 20127798
35. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. De Bari C, Dell'Accio F, Luyten F, Arthritis Rheum 2001 44 85 95 10.1002/1529-0131(200101) 44:1<85::AID-ANR12>3.0.CO;2-6 11212180 (Pubitemid 32113122)
36. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan I, Archer C, Jones E, McGonagle D, Mitsiadis T, Pitzalis C, Arthritis Rheum 2006 54 1209 1221 10.1002/art.21753 16575900 (Pubitemid 43672933)
37. Clonal analysis for developmental potential of chick periosteum-derived cells: agar gel culture system. Nakase T, Nakahara H, Iwasaki M, Kimura T, Kimata K, Watanabe K, Caplan A, Ono K, Biochem Biophys Res Commun 1993 195 1422 1428 10.1006/bbrc.1993.2202 8216278 (Pubitemid 23290312)
38. Multipotent mesenchymal stem cells from adult human synovial membrane. De Bari C, Dell'Accio F, Tylzanowski P, Luyten F, Arthritis Rheum 2001 44 1928 1942 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P 11508446 (Pubitemid 32758241)
39. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Jones E, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, Emery P, Hatton P, McGonagle D, Arthritis Rheum 2008 58 1731 1740 10.1002/art.23485 18512779 (Pubitemid 351847527)
40. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D, Arthritis Rheum 2002 46 3349 3360 10.1002/art.10696 12483742 (Pubitemid 35453547)
41. The surface of articular cartilage contains a progenitor cell population. Dowthwaite G, Bishop J, Redman S, Khan I, Rooney P, Evans D, Haughton L, Bayram Z, Boyer S, Thomson B, J Cell Sci 2004 117 889 10.1242/jcs.00912 14762107 (Pubitemid 38386946)
42. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Koelling S, Kruegel J, Irmer M, Path J, Sadowski B, Miro X, Miosge N, Cell stem cell 2009 4 324 335 10.1016/j.stem.2009. 01.015 19341622
43. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, Sonoyama W, Li L, Leet AI, Seo BM, Zhang L, Shi S, Young MF, Nat Med 2007 13 1219 1227 10.1038/nm1630 17828274 (Pubitemid 47530625)
44. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C, Stem Cells Dev 2008 17 761 773 10.1089/scd.2007.0217 18393634
45. An essential role of NF-kappaB in the "tumor-like" phenotype of arthritic synoviocytes. Li X, Makarov SS, Proc Natl Acad Sci USA 2006 103 17432 17437 10.1073/pnas.0607939103 17088540 (Pubitemid 44788986)
46. Present status of and future direction for articular cartilage repair. Wakitani S, Kawaguchi A, Tokuhara Y, Takaoka K, J Bone Miner Metab 2008 26 115 122 10.1007/s00774-007-0802-8 18301966 (Pubitemid 351317128)
47. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, Weber R, Ewerbeck V, Richter W, Arthritis Rheum 2003 48 418 429 10.1002/art.10767 12571852 (Pubitemid 36278011)
48. Tensile properties of engineered cartilage formed from chondrocyte-and MSC-laden hydrogels. Huang A, Yeger-McKeever M, Stein A, Mauck R, Osteoarthritis Cartilage 2008 16 1074 1082 10.1016/j.joca.2008.02.005 18353693
49. Stem cell therapy in a caprine model of osteoarthritis. Murphy J, Fink D, Hunziker E, Barry F, Arthritis Rheum 2003 48 3464 3474 10.1002/art.11365 14673997 (Pubitemid 37531912)
50. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Liu Y, Shu X, Prestwich G, Tissue Eng 2006 12 3405 3416 10.1089/ten.2006.12.3405 17518677 (Pubitemid 46037164)
51. ClinicalTrials.gov: A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy. http://www.clinicaltrials.gov/ ct2/show/NCT00225095?term=chondrogen&rank=2
52. ClinicalTrials.gov: Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration. http://www.clinicaltrials.gov/ct2/show/NCT00881023?term=CAIS&rank=1
53. ClinicalTrials.gov:Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee (TGC-03-01). http://www.clinicaltrials.gov/ct2/show/ NCT00599248?term=TissueGene&rank=1
54. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W, J Am Coll Cardiol 2009 54 2277 2286 10.1016/j.jacc.2009.06.055 19958962
55. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K, Scand Cardiovasc J 2005 39 150 158 10.1080/14017430510009131 16152682 (Pubitemid 41657525)
56. Mesenchymal stem cell therapy: Two steps forward, one step back. Ankrum J, Karp JM, Trends Mol Med 2010 16 203 209 10.1016/j.molmed.2010.02.005 20335067